IT’S TIME TO KICK OFF LIVES 2018…

OPENING SESSION – Full session online ESICM’s 31st Annual Congress sees its official start on Sunday, October 21st with an Opening Session featuring some of the top experts in intensive care medicine and some timely and inspiring keynote presentations to ensure you begin your LIVES 2018 experience on a high point… Want to see the full […]

Read More…

(icTV) PRESIDENT’S MESSAGE

“What counts the most is the human contact…” In this icTV interview, President Massimo Antonelli shares a few details about the LIVES 2018 opening session and takes a moment to reflect on his presidency and to thank the members for their active participation in the society. He discusses some of the best moments of his […]

Read More…

The LIVES 2018 App: FREE TO DOWNLOAD NOW!

Download the LIVES 2018 App here: App Store Googleplay   This is your essential tool to fully connect to ESICM’s 31th Annual Congress LIVES 2018… GET CONNECTED NOW! […]

Read More…

Augmented renal clearance: Impact on continuously infused TZP concentrations?

Does augmented renal clearance have a negative impact on continuously infused TZP concentrations? EJRC Article Review Inappropriate antibiotic dosing has been linked to adverse infection outcomes1,2. Augmented renal clearance (ARC, >130mL/min) has been identified as a risk factor for low beta-lactam antibiotic concentrations in ICU patients 5,6. Because beta-lactam antibiotics have time-dependent killing properties, prolonging […]

Read More…

e-LIVES: October Highlights

e-LIVES: October Highlights Special interest sessions @LIVES 2018 This month we feature 6 top sessions which will be on offer at LIVES 2018 in Paris: Changing the paradigm: Personalised antibiotic dosing for the critically ill 22.10.2018 08:00-08:20 Presidents’ Ground Breaking Research Release 22.10.2018 16:00-18:11 ARDS phenotyping: A new era for clinical trials? 23.10.2018 08:00-08:20 Clinical […]

Read More…

Ventilator-associated complications in patients with ESBLE infections

Ventilator-associated complications in patients with ESBLE infections EJRC Article Review   Extended-spectrum b-lactamase producing Enterobacteriaceae (ESBLE) colonise a growing proportion of critically ill patients in the intensive care unit (ICU)[1]. ESBLE colonisation is an established risk factor for subsequent infections [2]. Although guidelines suggest to consider the colonisation status of patients to adjust empirical treatment […]

Read More…